Neurology Central

Immunotherapy may be an effective treatment for some gliomas

A recent study involving 25 international institutions, led by researchers from Columbia University Vagelos College of Physicians and Surgeons (NY, USA) and published in Nature Medicine, has revealed that gliomas in neurofibromatosis type 1 (NF1) patients may be effectively treated by immunotherapy.

NF1 can cause slow-growing gliomas in children and aggressive forms of the tumor in adults, both of which are challenging to treat with conventional means.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.